Medicine and Dentistry
17 Methylnaltrexone
13%
Academic Detailing
20%
Advanced Cancer
9%
Amyotrophic Lateral Sclerosis
20%
Arm
25%
Bowel Obstruction
20%
Brief Pain Inventory
5%
Cancer Pain
20%
Care Group
5%
Chemotherapy-Induced Peripheral Neuropathy
5%
Chronic Obstructive Pulmonary Disease
27%
Clinician
8%
Diseases
14%
Dyspnea
100%
End of Life Care
20%
Endorphin
20%
Exercise
10%
Exhalation
20%
Fumaric Acid Dimethyl Ester
20%
General Practitioner
20%
Histamine
20%
Home Oxygen Therapy
20%
Low Drug Dose
7%
Malignant Neoplasm
5%
Morphine
6%
Motor Neuron Disease
20%
Naloxone
10%
Noninvasive Ventilation
13%
Octreotide
20%
Opioid Receptor
16%
Oscillometry
20%
Outpatient
6%
Patient with Asthma
8%
Pharmacological Treatment
5%
Placebo
40%
Pregabalin
20%
Quality of Life
32%
Randomized Controlled Trial
60%
Rating Scale
5%
Side Effect
6%
Spirometry
11%
Symptomatic Treatment
16%
Table Salt
5%
Thirst
20%
Xerostomia
20%
Nursing and Health Professions
Base
6%
Care Pathway
10%
Clinical Assessment
10%
Clinical Guideline
10%
Diseases
18%
Dyspnea
20%
Health Care Personnel
20%
Health Practitioner
10%
Histamine
20%
Home Oxygen Therapy
20%
Intensive Care Unit
8%
Intestine Obstruction
20%
Medical Staff
20%
Medical Student
20%
Motor Neuron Disease
20%
Nerve Block
20%
Nursing Staff
5%
Occupational Therapist
10%
Octreotide
20%
Oscillometry
20%
Palliative Therapy
88%
Patient Population
6%
Patient with Asthma
8%
Physician
20%
Placebo
22%
Practice Guideline
10%
Pulse Oximetry
20%
Quality of Life
20%
Registered Nurse
10%
Self Care
8%
Shoulder Pain
20%
Spirometry
8%
Syndrome
20%
Terminal Care
42%
Xerostomia
60%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
20%
Chronic Obstructive Lung Disease
25%
Constipation
5%
Dyspnea
40%
Endorphin
20%
Essential Drug
20%
Fumaric Acid Dimethyl Ester
20%
Intestine Obstruction
20%
Laxative
5%
Methylnaltrexone
13%
Morphine
20%
Motor Neuron Disease
20%
Naloxone
10%
Number Needed to Treat
5%
Observational Study
5%
Octreotide
20%
Opiate Receptor
16%
Pharmacovigilance
20%
Phase IV
5%
Placebo
40%
Randomized Controlled Trial
45%
Shoulder Pain
20%
Side Effect
10%
Sustained Release
20%
Table Salt
5%
